Fernarzt

News

There’s a new kid on the block in digital health – called HealthHero – with aspirations to become the biggest company in the European market.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.